Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

Xuemin Jiang(The University of Sydney), Andrew J. McLachlan(The University of Sydney), Alaina J. Ammit(Woolcock Institute of Medical Research), Colin C. Duke(The University of Sydney), Winston Liauw(St George Hospital), Basil D. Roufogalis(The University of Sydney), Kenneth M. Williams(UNSW Sydney), Richard O. Day(St Vincent's Hospital Sydney)
British Journal of Clinical Pharmacology
February 3, 2004
10.1111/j.1365-2125.2003.02051.x
Cited by 272

Related Papers

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
|BMJ|2015|577
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467
Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
|Clinical Pharmacokinetics|2000|424